Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stock Watcher's Thread / Pix of the Week (POW) -- Ignore unavailable to you. Want to Upgrade?

To: Stock Watcher who wrote (19746)	11/23/1999 11:25:00 AM
From: mph	Respond to of 52051

thanks, sw. In both myself....

To: Stock Watcher who wrote (19746)	11/23/1999 11:27:00 AM
From: BlueCheap	Respond to of 52051

FONAR Makes First Sale of Its Small, Low-cost MRI Scanner FONAR Makes First Sale of Its Small, Low-cost MRI Scanner Business & Health Editors MELVILLE, N.Y.--(BW HealthWire)--Nov. 23, 1999--FONAR Corporation (NASDAQ-FONR), The Open MRI Company(TM), announced today its first sale of The Echo(TM), the company's new .35 Tesla compact unit designed to sell in world markets with an economic need for a lower-priced scanner. FONAR's first sale of The Echo(TM) was to a medical center in Puerto Rico, representing the facility's first MRI scanner purchase. The scanner sold for approximately $600,000, roughly half the price of a .6 Tesla scanner. The Echo(TM) is the smallest and least expensive scanner on the market, yet utilizes the highest technology available. Images from The Echo(TM) will be unveiled at the Radiological Society of North America (RSNA), the world's largest medical trade show, starting on November 28 in Chicago. "Until The Echo(TM) became available, this medical center in Puerto Rico found MRI scanners to be prohibitively expensive and outside of their budget," said Raymond Damadian, president and founder of FONAR. "We are gratified that cost-conscious communities will now be able to obtain The Echo(TM) to help aid in the early detection of cancer and other diseases in markets in which MRI technology was previously unavailable." "We also plan to sell The Echo(TM) to medical centers that already own a high-end scanner but are looking to add a second scanner to their practice," said Sol Ginzburg, vice president of sales for FONAR. "This scanner makes the purchase of a second scanner feasible." In 1980, FONAR introduced the world's first commercial MRI whole-body scanner. The widespread application of Magnetic Resonance Imaging (MRI) in medicine and biology today is the direct result of the landmark discoveries and early pioneering work of Dr. Damadian. His seminal discoveries of the variations in soft body tissue relaxation times, as well as the cancer detecting NMR signal, are the means used by all MRI scanners to detect cancer and distinguish healthy versus diseased tissues. A 1997 U.S. Supreme Court ruling affirmed that Dr. Damadian's patented discoveries are fundamental to every MRI unit in the marketplace today. Be sure to visit FONAR's Web site for Company product and investor information. www.fonar.com This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission. --30--jp/ny* mjr CONTACT: FONAR Corporation Daniel Culver, Director of Communications and David Terry, VP, Secretary 516/694-2929 FAX: 516/390-9540 investor@fonar.com